MHRA - New streamlined notification scheme for lowest-risk clinical trials marks start of MHRA overhaul of regulation

12th October 2023

UK patients, the healthcare system and the life sciences sector are set to benefit from a new scheme that will see the time taken by the Medicines and Healthcare products Regulatory Agency (MHRA) to approve the lowest-risk clinical trials reduced by more than 50%.

Click here for more.

Back to News Archive